The World Health Organization (WHO) has backed the first malaria vaccine, which could be especially beneficial in areas such as sub-Saharan Africa with moderate to high malaria transmission rates. In 2019, malaria caused 409,000 deaths, according to WHO. The vaccine from GlaxoSmithKline (NYSE:GSK) specifically targets plasmodium falciparum, a malaria strain common in sub-Saharan Africa. Plasmodium falciparum…
How AI technology can democratize clinical trials in oncology
While drug developers continue to develop promising investigational cancer drugs, conducting clinical research in oncology remains difficult. Here’s how AI-enabled software can help. The statistics on inadequate trial recruitment and endemic challenges in oncology clinical trials are well known. They have only gotten worse over the past 20 years. While the number of cancer treatments…
10 Cancer Drugs that Made Headlines This Year
The U.S. saw a reduction in cancer deaths from 1991 to 2014. According to the latest data from the 2017 Cancer Progress Report, just released by the American Association of Cancer Research (AACR), over 2.1 million lives have been saved. The AACR cites immunotherapy and precision medicine are at the forefront of this progress. Its…